Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release

Kyle T. Hufziger, Fathima Shazna Thowfeik, David J. Charboneau, Ismael Nieto, William G. Dougherty, W. Scott Kassel, Timothy J. Dudley, Edward J. Merino, Elizabeth T. Papish, Jared J. Paul

    Research output: Contribution to journal › Article › peer-review

    47 Scopus citations

    Fingerprint

    Dive into the research topics of 'Ruthenium dihydroxybipyridine complexes are tumor activated prodrugs due to low pH and blue light induced ligand release'. Together they form a unique fingerprint.

    Medicine & Life Sciences

    Chemical Compounds